April 13, 2023
Nihon Medi-Physics, a Japanese radiopharmaceutical specialist, said on April 10 that it has filed for a label expansion of its amyloid PET imaging agent Vizamyl Injection (flutemetamol 18 F), considering its use in patients who might receive Alzheimer’s disease (AD)-modifying...read more